Which of the following provides the best data to show that a patient with Type 1 diabetes is adhering to their treatment regimen?

This question evaluates the nurse's role in the evaluation phase of the nursing process following medication administration. It requires understanding that assessing clinical outcomes is essential to determine whether the intended therapeutic goals have been achieved or if adjustments to the plan of care are required.

Choice A rationale

While recording the dose administered is a component of accurate documentation and medication safety, evaluating the actual therapeutic response is the most important step to determine if the clinical intervention successfully met the patient's specific health needs.

Choice B rationale

The time of administration is a required element of medication documentation to ensure patient safety and adherence to a schedule. However, it does not provide any information regarding the patient's clinical response or the effectiveness of the drug.

Choice C rationale

Assessing for patient allergies is a critical safety step that must be performed prior to any medication administration. Evaluating this after administration is too late to prevent an adverse drug reaction and does not assess clinical therapeutic efficacy.

Choice D rationale

The primary purpose of medication therapy is to achieve a specific physiological change. Evaluating the therapeutic effect allows the nurse to confirm the drug's success in managing the patient's symptoms and guides future decisions regarding ongoing pharmacological treatment plans.

This question addresses the monitoring requirements for patients receiving potent opioid analgesics. It requires applying knowledge of opioid-induced respiratory depression, which is the most dangerous potential adverse effect, requiring constant vigilance to ensure patient safety and prevent hypoxic events during the postoperative recovery period.

Choice A rationale

While opioids can cause hypotension due to peripheral vasodilation, it is not as acutely life-threatening as respiratory depression. Blood pressure monitoring is important but secondary to the immediate, time-critical need to ensure the patient maintains a safe and effective rate of breathing.

Choice B rationale

Opioids do not typically cause direct changes to body temperature. While temperature monitoring is part of standard postoperative care to detect infection or other complications, it is not the primary vital sign concern when administering a dose of hydromorphone.

Choice C rationale

Hydromorphone is a powerful opioid that acts on central nervous system receptors to suppress the respiratory drive. Shallow respirations or a low respiratory rate are the most serious adverse effects, requiring immediate assessment to prevent respiratory arrest and significant patient harm.

Choice D rationale

Opioids can cause bradycardia, but this is generally managed effectively unless the patient is hemodynamically unstable. Heart rate is a vital parameter to monitor, but it is not the primary physiological concern following the administration of a potent opioid medication..